Oswaldo Cruz Foundation-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Oswaldo Cruz Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013305
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ブラジル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Oswaldo Cruz Foundation (Oswaldo Cruz) is a provider of research development, vaccines production, drugs, reagents and diagnostic kits. The foundation provides research in experimental models of disease, infectious agent vector biology, information and communication in health, management of science and technology, microbiology, molecular and genetic epidemiology, and others. It offers public laboratories for vaccine production. The foundation offers vaccines such as DTP and haemophilus influenzae type B, yellow fever, haemophilus influenzae type B, meningitis A and C, poliomyelitis and measles, mumps and rubella. Oswaldo Cruz is headquartered in Rio de Janeiro, Brazil.

Oswaldo Cruz Foundation – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Oswaldo Cruz Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Oswaldo Cruz Foundation, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Oswaldo Cruz Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Oswaldo Cruz Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Oswaldo Cruz Foundation, Medical Devices Deals, 2011 to YTD 2017 9
Oswaldo Cruz Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Oswaldo Cruz Foundation, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Sanofi Pasteur Expands R&D Agreement with Walter Reed Army Institute of Research and Bio Manguinhos and Fiocruz 11
Globavir Enters into Co-Development Agreement with Biomanguinhos 12
GenCell Biosystems To Enter Into Agreement With Fiocruz, Institute Of Molecular Biology Of Parana And Immunobiological Technology Institute To Develop Clinical Screening Systems 13
Protalix Enters Into Technology Transfer Agreement With Oswaldo Cruz Foundation For Uplyso 14
Eisai Enters Into R&D Agreement With Oswaldo Cruz Foundation For Malaria And Neglected Tropical Diseases 16
Biomm Enters Into Agreement With Fundacao Oswaldo Cruz To Develop Insulin 17
Licensing Agreements 18
iBio Extends its Licensing Agreement with Bio-Manguinhos 18
iBio Enters Into Licensing Agreement With Bio-Manguinhos 19
Oswaldo Cruz Foundation – Key Competitors 20
Oswaldo Cruz Foundation – Key Employees 21
Oswaldo Cruz Foundation – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Joint Venture 22
Recent Developments 23
Government and Public Interest 23
Jul 27, 2016: IBM Intensifies Fight Against Zika 23
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Oswaldo Cruz Foundation, Pharmaceuticals & Healthcare, Key Facts 2
Oswaldo Cruz Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Oswaldo Cruz Foundation, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Oswaldo Cruz Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Oswaldo Cruz Foundation, Deals By Therapy Area, 2011 to YTD 2017 8
Oswaldo Cruz Foundation, Medical Devices Deals, 2011 to YTD 2017 9
Oswaldo Cruz Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Sanofi Pasteur Expands R&D Agreement with Walter Reed Army Institute of Research and Bio Manguinhos and Fiocruz 11
Globavir Enters into Co-Development Agreement with Biomanguinhos 12
GenCell Biosystems To Enter Into Agreement With Fiocruz, Institute Of Molecular Biology Of Parana And Immunobiological Technology Institute To Develop Clinical Screening Systems 13
Protalix Enters Into Technology Transfer Agreement With Oswaldo Cruz Foundation For Uplyso 14
Eisai Enters Into R&D Agreement With Oswaldo Cruz Foundation For Malaria And Neglected Tropical Diseases 16
Biomm Enters Into Agreement With Fundacao Oswaldo Cruz To Develop Insulin 17
iBio Extends its Licensing Agreement with Bio-Manguinhos 18
iBio Enters Into Licensing Agreement With Bio-Manguinhos 19
Oswaldo Cruz Foundation, Key Competitors 20
Oswaldo Cruz Foundation, Key Employees 21
Oswaldo Cruz Foundation, Subsidiaries 22
Oswaldo Cruz Foundation, Joint Venture 22

★海外企業調査レポート[Oswaldo Cruz Foundation-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Euro India Fresh Foods Ltd (EIFFL):企業の財務・戦略的SWOT分析
    Euro India Fresh Foods Ltd (EIFFL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Laboratorio Teuto Brasileiro SA-製薬・医療分野:企業M&A・提携分析
    Summary Laboratorio Teuto Brasileiro SA (Teuto), a subsidiary of Pfizer Inc is a drug company that develops, manufactures, and markets generic and over the counter products. The company’s products include aerodini aerosol salbutamol sulphate, afopic folic acid, albentel albendazole, acetato de dexam …
  • MaaT Pharma-製薬・医療分野:企業M&A・提携分析
    Summary MaaT Pharma (MaaT) is a biotechchnology company that develop novel treatments for Gut Microbiota - dysbiosis related diseases. The company is working on two projects, which are in the developmental stage, namely, MaaT001, an innovative live frozen inoculum suspension and MaaT002, an innovati …
  • Anthem Inc (ANTM)-製薬・医療分野:企業M&A・提携分析
    Summary Anthem Inc (Anthem), formerly WellPoint Inc, is a health benefits company. It offers several managed healthcare related products and related administrative services. It also provides various specialty and insurance products and services including radiology benefit management, dental, life an …
  • Guyana Goldfields Inc:企業の戦略・SWOT・財務情報
    Guyana Goldfields Inc - Strategy, SWOT and Corporate Finance Report Summary Guyana Goldfields Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Aohata Corporation:企業の戦略・SWOT・財務情報
    Aohata Corporation - Strategy, SWOT and Corporate Finance Report Summary Aohata Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Warpaint London plc (W7L):企業の財務・戦略的SWOT分析
    Warpaint London plc (W7L) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Synairgen Plc (SNG):製薬・医療:M&Aディール及び事業提携情報
    Summary Synairgen plc (Synairgen) is a drug discovery and development company, which focuses on the development of novel drugs for the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Its pipeline portfolio includes inhaled interferon beta (IFN-ß/SNG …
  • UGI Corp (UGI):企業の財務・戦略的SWOT分析
    UGI Corp (UGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • International Flavors & Fragrances Inc.:戦略・SWOT・企業財務分析
    International Flavors & Fragrances Inc. - Strategy, SWOT and Corporate Finance Report Summary International Flavors & Fragrances Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Alesi Surgical Ltd-医療機器分野:企業M&A・提携分析
    Summary Alesi Surgical Ltd (Alesi Surgical), formerly Asalus Medical Instruments Ltd is a medical device company that develops devices for minimal access surgery. The company offers surgical smoke control system. Its product is used to clear surgical smoke from the visual field and to prevent its re …
  • Rosneft Oil Co (ROSN):企業の財務・戦略的SWOT分析
    Rosneft Oil Co (ROSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Marquette Capital Partners LLC:企業の戦略・SWOT・財務情報
    Marquette Capital Partners LLC - Strategy, SWOT and Corporate Finance Report Summary Marquette Capital Partners LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Pacific Edge Ltd (PEB)-医療機器分野:企業M&A・提携分析
    Summary Pacific Edge Ltd (PEB) is a diagnostics company that discovers, develops and commercializes diagnostic tests for the early detection and monitoring of cancer. The company provides lead product such as Cxbladder, a non-invasive laboratory test for the detection of bladder cancer. It is develo …
  • Heineken NV:企業の戦略・SWOT・財務分析
    Heineken NV - Strategy, SWOT and Corporate Finance Report Summary Heineken NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Kuwait National Petroleum Co:企業の戦略・SWOT・財務情報
    Kuwait National Petroleum Co - Strategy, SWOT and Corporate Finance Report Summary Kuwait National Petroleum Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Penta-Ocean Construction Co Ltd:戦略・SWOT・企業財務分析
    Penta-Ocean Construction Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Penta-Ocean Construction Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • SpineGuard SA (ALSGD):医療機器:M&Aディール及び事業提携情報
    Summary SpineGuard SA (SpineGuard) is a medical device company that designs, develops and markets spine surgery products. The company offers PediGuard, a device that detects possible vertebral cortex perforation during pedicle preparation. It provides offers screw placement and alerts to surgeon pri …
  • The Co-operative Bank Plc:企業の戦略・SWOT・財務情報
    The Co-operative Bank Plc - Strategy, SWOT and Corporate Finance Report Summary The Co-operative Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • GVK Power and Infrastructure Ltd (GVKPIL):企業の財務・戦略的SWOT分析
    GVK Power and Infrastructure Ltd (GVKPIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆